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Does the timing of reoperation influence the risk
of graft infection?
Stephen Kolakowski, Jr, MD, Matthew J. Dougherty, MD, and Keith D. Calligaro, MD, Philadelphia, Pa
Objective: This study compared the incidence and characteristics of graft infection in patients who underwent early vs late
revisional surgery of lower extremity arterial bypass grafts.
Methods: Between 1992 and July 2005, 500 revisional procedures were performed on 198 lower extremity bypass grafts.
Patients whose revisions were performed <30 days after the primary bypass were in the early revision (ER) group (n 
99), and those done>30 days after bypass were in the late revision (LR) group (n 99). Infection was defined as cellulitis
with graft exposure or purulence in continuity with a graft that required antibiotics and operation for infection control.
Mean follow-up was 60 months (range, 2 to 60 months). Groups were compared using Student’s t test.
Results: The ER group included 66 autogenous and 33 prosthetic grafts. The LR group consisted of 53 autogenous and
46 prosthetic grafts. Of the 500 revisional procedures performed, 17 graft infections occurred (3.4%). Twelve (70.6%)
were prosthetic grafts and five (29.4%) were autogenous grafts (P  .004). Defining the infection rate per graft rather
than per revisional procedure, the ER group had a significantly higher graft infection rate at 11% (11/99) compared with
6.1% in the LR group (6/99; P .012). The risk of infection for prosthetic grafts was significantly higher within the ER
group at 27.3% (9/33) compared with autogenous grafts at 3.1% (2/66; P  .0001). Infection developed in three vein
grafts and three prosthetic grafts in the LR group (P NS). For prosthetic graft revisions only, infection risk was 27.3%
(9/33) in the ER group and 6.5% (3/46) in the LR group (P  .005). The most common cultured pathogen was
methicillin resistant Staphylococcus aureus (ER, 6/11 vs LR, 3/6; P  NS. Within the ER group, the prevalence of
Pseudomonas aeruginosa was significantly higher at 27.3% (3/11) compared with 0% (0/6) in the LR group (P  .04).
Conclusions: Early revision of lower extremity arterial bypass grafts has a significantly higher risk of graft infection
compared with revision >1 month after surgery. Infection will develop in approximately 25% (9/33) of prosthetic
grafts that are reoperated on early. If feasible, reoperation should be delayed >1 month for prosthetic grafts needing
revision. Endovascular or extra-anatomic interventions should be considered if early revision is mandated in this
group. ( J Vasc Surg 2007;45:60-4.)Infrainguinal bypass is a well-established therapeutic
option in patients with disabling claudication or threatened
limb loss. Graft failure remains a significant problem, how-
ever, with 5% to 20% of grafts failing in the first 30 days, and
20% to 50% failing 30 days.1 Postoperative duplex graft
surveillance is critical to identify a failing graft, and reinter-
vention of failing grafts, or those that have failed, allows
long-term salvage of many of these grafts.
Graft infection is a major complication associated with
reoperative surgery on lower extremity bypasses.2,3 These
are uncommon but can be a devastating complication with
high amputation and mortality rates.4-6 When a graft oc-
cludes or a surveillance study identifies a graft-threatening
lesion, the timing of surgery, risk of graft failure, severity of
ischemia, and risk of graft infection secondary to revision
surgery must be weighed. Although reoperation is a well-
established risk for infection,7-9 the magnitude of the risk
and the influence on timing of reoperative surgery has not
been established.
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60We have analyzed the type of bacteria associated with
early and late graft infections,2,3 and this study compared
the incidence and characteristics of graft infection after
revisional surgery of lower extremity arterial bypass grafts.
We questioned whether there is a difference in the inci-
dence of graft infection for early vs later graft revision. In
addition, we were interested in whether the type of conduit
used (autogenous or prosthetic) affected the incidence of
graft infection.10,11
METHODS
We identified patients who underwent revisional pro-
cedures on lower extremity bypass grafts between 1992 and
2005 by the vascular surgery service at Pennsylvania Hos-
pital in Philadelphia. Patients were classified as early revi-
sion (ER) if the revisional procedures was performed 30
days from the original operation and late revision (LR) if it
was performed 30 days after the original operation.
All procedures were performed in an endovascular op-
erating suite. The key outcome analyzed was graft infec-
tion, which was defined as cellulitis with graft exposure or
purulence in continuity with a graft requiring parenteral
antibiotic therapy and surgical operation for infection con-
trol. Patient demographics, clinical factors, and outcome
were recorded from office and hospital charts.
Clinical factors and outcome measures included vas-
cular conduit (autogenous or prosthetic), indications for
primary and revisional procedures, preoperative work-
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ogy, limb loss, and mortality. Indications for initial
operation included ulcer or gangrene, rest pain, or clau-
dication. Indications for revisional procedures identified
were thrombosed graft, failing graft, anastomotic bleed-
ing, and hematoma evacuation. Graft infections were
evaluated with intravenous contrast computed tomogra-
phy (CT) scans, and arteriography was used liberally.
Data were analyzed in accordance with suggested stan-
dards on reporting of lower extremity ischemia proce-
dures.12 Mean follow-up time for the cohort was 60
months. Groups were compared using Student’s t test and
analysis of variance valuation. P  .05 was defined as
statistically significant.
RESULTS
Between 1992 and 2005, 500 surgical revisions were
performed on 198 lower extremity bypass grafts, of which
99 had a revision30 days from the primary graft construc-
tion (ER), and 99 were identified in the LR group (revision
30 days). The ER group included 66 autogenous and 33
prosthetic grafts, and the LR group consisted of 53 autog-
enous and 46 prosthetic grafts (P  .059).
Preoperative demographics and risk factors are summa-
rized in Table I. Men comprised about 50% of the popula-
tion, and 75% of patients were white. There were no
significant differences in age, gender, ethnicity, the pres-
ence of hypertension, diabetes, hypercholesterolemia, and
chronic obstructive pulmonary disease, and primary surgi-
cal indication between the ER and LR groups or infected
grafts and those that did not develop infection.
Graft infections occurred in 17 (3.4%) of the 500
revisional procedures performed, of which 12 (70.6%) were
in prosthetic grafts and five (29.4%) were in autogenous
grafts (P  .004). No deaths occurred in the 17 patients
who developed infection.
Defining the infection rate over the lifetime of the
grafts that required revision, rather than per revisional
procedure, the overall graft infection rate was 8.6% (17/
198). The ER group had a significantly higher graft infec-
tion rate at 11.1% (11/99) compared with 6.1% ((6/99) in
the LR group (P  .012). Nine of the 11 graft infections
that occurred within the ER group were in prosthetic
grafts, and two were in autogenous grafts (9/33, 27.3% vs
Table 1. Patient demographics
Total population
Age 69.33  0.79
Sex (%) male 51.90  0.03
Race (%) white 75.00  0.02
Hypertension 77.14  0.02
Diabetes mellitus 40.00  0.03
Hypercholesterolemia 37.80  0.03
COPD 16.12  0.02
COPD, Chronic obstructive pulmonary disease.2/66, 3.1%; P .0001). Six graft infections occurred in theLR group: three each in prosthetic grafts and in vein grafts
(P  NS).
Considering prosthetic graft revisions only, infection
risk was 27.3% (9/33) in the ER group and 6.5% (3/46) in
the LR group (P .005). For autogenous grafts, infection
risk was 3.1% (2/64) vs 6.0% (3/50) for early vs late
revisions (P  NS).
The amputation rate among patients who developed
graft infection was 29.4% (5/17). All amputations that
were required occurred shortly after the onset of infection.
There was no statistical difference in limb salvage between
the ER (72.7%) and LR groups (66.6%).
The operative infection site and surgical indications
are listed in Table II. The groin incision was more likely
than other sites to be involved with infection, with 80%
of graft infections involving the groin. The most common
primary indication for surgery for grafts that ultimately
became infected was ulcer or gangrene (8/17). The most
common indication for revision among all infected grafts
was a thrombosed graft (9/17).
We further analyzed the number of revisions performed
on the graft after the initial surgery and before the diagnosis
of infection. Within the ER group, 54.5% (6/11) of the
infections occurred after only one intervention, and 45.5%
(5/11) presented after multiple revisional operations. In
Early revision Late revision P
68.67  1.14 69.58  1.15 .289
53.53  0.05 49.49  0.05 .285
76.76  0.04 75.51  0.04 .419
76.76  0.04 77.77  0.04 .433
46.46  0.05 36.36  0.04 .075
36.36  0.05 36.84  0.05 .945
16.16  0.03 16.16  0.37 .9999
Table II. Operative sites and indications
Early revision
n  11 (%)
Late revision
n  6 (%)
Infection site
Groin 10 (90.9) 5 (83.3)
Other 1 (9.1) 1 (16.7)
Primary operative indication
Ulcer/gangrene 4 (36.4) 4 (66.6)
Rest pain 5 (45.5) 1 (16.6)
Ulcer/rest pain 2 (18.1) 1 (16.6)
Reoperative indication
Thrombosed graft 7 (54.5) 2 (33.3)
Failing graft 0 4 (66.6)
Anastomotic bleed 2 (18.8) 0
Hematoma evacuation 2 (18.8) 0
Clinical infection criteria
Exposed graft 3 (27.3) 2 (33.3)
Purulent drainage 5 (45.4) 3 (50.0)
Disrupted anastomosis 3 (27.3) 1 (16.7)the LR group, 83.3% (5/6) of the infections occurred after
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pared with the rest of the cohort, of which 120 of 181 grafts
underwent only one intervention and 61 of 181 underwent
two or four interventions during the follow-up period. The
average interval between initial revision and subsequent
infection was 183.2 days (range, 37 to 592 days) in the ER
group and 301.4 days (range, 29 to 828 days) days in the
LR group (P  .112).
Infection in the ER group presented as three exposed
grafts with drainage, five perigraft abscesses or draining
sinuses, and three disrupted anastomoses. In the LR group,
there were two exposed grafts, three purulent drainage
sites, and one disrupted anastomosis.
The most common cultured pathogen was methicillin
resistant Staphylococcus aureus (MRSA) (ER, 6/11 vs LR,
3/6; PNS). Other bacteria identified included methicil-
lin sensitive S aureus, Pseudomonas aeruginosa, Alcaligenes
xylosoxidans, Serratia marcescens, and vancomycin-resistant
Enterococcus (Table III). The prevalence of grafts infected
with P aeruginosa was significantly higher in the ER group
at 27.3% (3/11) compared with the LR group at 0% (0/6;
P  .04).
DISCUSSION
Despite advances in surgical technique, infrainguinal
graft failure remains a significant problem. Early graft oc-
clusion, defined as 30 days after surgery, is often attrib-
uted to technical problems and occurs in 5% to 20% of
cases. Late graft failure (30 days) occurs in 20% to 50% of
cases.13 Although in our series the differences in the demo-
graphics and risk factors were not significant, the ER and
LR groups are not strictly comparable, and confounding
risk factors may influence the infection rate.
Infection is a known complication of any revisional
surgery. In this series, the overall graft infection rate was
8.5%, which is somewhat high but within the 2.5% to 12%
range reported by others.14-17 This may reflect the fact that
all grafts underwent at least one surgical revision to be
included in this series. Two thirds of the graft infections
occurred in ER group, and80% of the infections involved
prosthetic grafts.
Most vascular surgeons try to avoid using prosthetic
grafts in the setting of foot ulcers and gangrene. We also
avoid prosthetic grafts in this setting, if possible, but there
Table III. Microbiology
Organism Early revision (n) Late revision (n)
MR Staphylococcus aureus 6 3
MS Staphylococcus aureus 3 1
Pseudomonas aeruginosa 3 0
Alcaligenes xylosoxidans 1 1
Serratia marcescens 1 0
VR Enterococcus 0 1
Polymicrobial 1 0
MR, Methicillin resistant; MS, methicillin sensitive; VR, vancomycin-
resistant.are times when no suitable conduit is available, and pros-thetic grafts have been used after appropriate institution of
antibiotics and local measures for infection. There was no
statistically significant increased risk of infection within
these subgroups, but our sample size was relatively small.
As might be expected, the ER group included a signif-
icant number of acute graft thromboses that prompted
emergent or urgent surgical intervention. The presence of
thrombosis at the time of revision appears to increase the
risk of graft infection. This may reflect the fact that throm-
bus, wound seroma, lymphatic interruption, and hema-
toma provide a rich medium for bacterial growth and are
relatively poorly penetrated by parenteral antibiotics. Oth-
ers have shown that the presence of a thrombosed pros-
thetic graft near a patent prosthetic bypass may increase the
risk of infection of the functioning graft.18
When the 17 graft infections were reviewed, we found
that four grafts had predisposing factors that may have led
to the graft infection. Two of the grafts developed hema-
toma after the original operation that required reoperation,
one developed a lower extremity cellulitis requiring intra-
venous antibiotics after a revisional procedure, and one
graft developed a lymphocele requiring drainage.
All patients with infrainguinal bypass are placed in a
duplex ultrasound surveillance protocol in our institution.
In 62 of the cohort of 198 duplexes, evidence of graft
stenosis was the indication for the primary revisional pro-
cedure. In the LR group, most of the operations were
performed for duplex ultrasound evidence of a failing graft.
The LR grafts tended to be well incorporated, and revision
occurred in a more elective situation, which may account
for the lower infection rate.
Infections that developed in the LR group occurred
after a longer interval from the time of revision compared
with the ER group, 301 vs 183 days, respectively. Although
this did not achieve statistical significance, the trend may
also reflect that well-incorporated and patent grafts are
relatively resistant to infection. In the ER grafts, a lack of
resistance to bacterial inoculation may lead to a more rapid
clinical evidence of graft infection. Of note, the interval
between revision and infection in both groups was unex-
pectedly long. This adds some doubt that the revision was
the key factor in the development of the infection rather
than the original operation or a remote issue.
Eighty percent of the grafts in the ER group that
developed infection were prosthetic. Autogenous grafts can
become infected but clearly are more resistant to this com-
plication than prosthetic grafts.
Most of the graft infection in both groups occurred
after a single revision, but the remainder had two to four
revisions. We were not able to break down the multiple-
revision groups into small subgroups to analyze for statis-
tical significance because the sample sets are too small.
Regardless of the timing of revision, MRSA was the
most common infecting pathogen, with a higher preva-
lence in the ER group. MRSA has emerged as the leading
cause of postoperative infection in vascular surgery,19,20
andMRSA graft infection is associated with higher morbid-
ity and amputation rates compared with other pathogens,
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MRSA tend to present earlier than infections with other
organisms occurring from direct seeding from colonized
skin at the time of operation.23 Unexpectedly, we had no
documented cases of S epidermidis. Groin incisions were
the site of 88% of all the infections. Direct contamination of
grafts from groin organisms is a common cause of graft
infection.8
The definition and description of early wound compli-
cations can be inconsistent, making it difficult to collect this
data retrospectively. Indeed, this is why we had a fairly
rigorous definition for graft infection, which was cellulitis
with graft exposure or purulence in continuity with a graft
that required parenteral antibiotic therapy and surgical
operation for infection control and requiring operative
control. One patient (1/17) had a noninfectious wound
complication of a lymphocele that required drainage.
Lymphatic spread of organisms from a pedal infection
site has also been implicated in early prosthetic graft infec-
tion, with disrupted inguinal nodal basins providing ac-
cess.24 Cultures were not routinely done for foot ulcers, so
we are unable to correlate with cultures taken at time of
graft infection with the presenting foot ulcer.
All patients undergoing a revisional procedure should
be treated with antibiotics appropriate for MRSA and
gram-negative flora.20,21,25,26 In addition to appropriate
spectrum, the surgeon must ensure proper administration
time (1 hour before incision) and repeated dosing to main-
tain effective serum and tissue levels throughout the oper-
ation. The optimal duration of antibiotic coverage remains
unclear, however. We generally maintain prophylactic ther-
apy for 48 hours for early revisional procedures on pros-
thetic grafts, although this is not based on any supporting
data.
In our series, the highest risk for infection is early
revision of a prosthetic graft. The sobering finding that
more than one quarter (9/33) of prosthetic grafts that
underwent early revision ultimately developed infection
mandates reappraisal of our approach in these patients.
Ideally, early graft exploration should be avoided or de-
layed if limb ischemia is tolerated. Unfortunately, delaying
intervention may not be an acceptable strategy with acute
graft occlusion and severe ischemia or with postoperative
bleeding, which was the case in all of our early revisional
procedures that developed infection.
Because 80% of graft infections occurred at a groin
wound, avoidance of reopening the groin seems prudent if
feasible. Extra-anatomic approaches to graft replacement
should be considered and is one of our favored strategies,
especially using the external iliac artery as a virgin inflow
source approached retroperitoneally through a small trans-
verse suprainguinal incision and tunneling a new graft
laterally around the previous groin incision to a more distal
site on the pre-existing graft.
More recently, endovascular interventions, such as me-
chanical thrombectomy or subintimal angioplasty of chronic
occlusions, have been used in preference to reopening fresh
surgical wounds. If groin wounds must be explored early,meticulous wound closure technique is important. Postoper-
ative avoidance of skinmoisture, maceration, and fungal over-
growth in the groin area are likewise critical.
CONCLUSIONS
Early revision of lower extremity arterial bypass grafts
carries a significantly higher risk of graft infection compared
with revision1month after surgery. Infectionwill ultimately
develop in as many as one quarter of prosthetic grafts reoper-
ated on early, withMRSAbeing themost common pathogen.
If feasible, reoperation for prosthetic grafts that need revision
should be delayed 1 month. When reoperation early is
mandated, strategic planning is essential, as is appropri-
ate antibiotic use and sterile technique. Endovascular or
extra-anatomic interventions should be considered if
early revision is mandated in this group, and groin
incisions should be avoided if possible.
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